Cellular proliferation and tissue remodeling are central to the regenerative response after a toxic injury to the liver. To explore the role of plasminogen in hepatic tissue remodeling and regeneration, we used carbon tetrachloride to induce an acute liver injury in plasminogen-deficient (Plg o ) mice and nontransgenic littermates (Plg ؉ ). On day 2 after CCl4, livers of Plg ؉ and Plg o mice had a similar diseased pale͞lacy appearance, followed by restoration of normal appearance in Plg ؉ livers by day 7. In contrast, Plg o livers remained diseased for as long as 2.5 months, with a diffuse pale͞lacy appearance and persistent damage to centrilobular hepatocytes. The persistent centrilobular lesions were not a consequence of impaired proliferative response in Plg o mice. Notably, fibrin deposition was a prominent feature in diseased centrilobular areas in Plg o livers for at least 30 days after injury. Nonetheless, the genetically superimposed loss of the A␣ fibrinogen chain (Plg o ͞Fib o mice) did not correct the abnormal phenotype. These data show that plasminogen deficiency impedes the clearance of necrotic tissue from a diseased hepatic microenvironment and the subsequent reconstitution of normal liver architecture in a fashion that is unrelated to circulating fibrinogen.
Cellular proliferation and tissue remodeling are central to the regenerative response after a toxic injury to the liver. To explore the role of plasminogen in hepatic tissue remodeling and regeneration, we used carbon tetrachloride to induce an acute liver injury in plasminogen-deficient (Plg o ) mice and nontransgenic littermates (Plg ؉ ). On day 2 after CCl4, livers of Plg ؉ and Plg o mice had a similar diseased pale͞lacy appearance, followed by restoration of normal appearance in Plg ؉ livers by day 7. In contrast, Plg o livers remained diseased for as long as 2.5 months, with a diffuse pale͞lacy appearance and persistent damage to centrilobular hepatocytes. The persistent centrilobular lesions were not a consequence of impaired proliferative response in Plg o mice. Notably, fibrin deposition was a prominent feature in diseased centrilobular areas in Plg o livers for at least 30 days after injury. Nonetheless, the genetically superimposed loss of the A␣ fibrinogen chain (Plg o ͞Fib o mice) did not correct the abnormal phenotype. These data show that plasminogen deficiency impedes the clearance of necrotic tissue from a diseased hepatic microenvironment and the subsequent reconstitution of normal liver architecture in a fashion that is unrelated to circulating fibrinogen. T he ability of the liver to regenerate after a physical or toxic injury requires both a well orchestrated proliferation of liver cells as well as tissue remodeling events to restore hepatic architecture. Although the control of the proliferative response is not fully understood, the cytokine-mediated activation of the signal transducer and activator of transcription-3 (1, 2), inducible nitric oxide synthetase (3) , and CCAAT enhancer-binding protein-␤ (4) have been shown to play key roles in the regulation of hepatocyte proliferation and maintenance of glucose homeostasis during liver regeneration. Concomitant to these processes, the regenerating liver also requires the restructuring of the extracellular matrix (ECM) to restore the functional and lobular organization of proliferating cells. The hepatic ECM forms a dynamic scaffold for liver cells, serves as a reservoir for growthrelated molecules, and undergoes degradation during liver regeneration, rendering hepatocytes responsive to mitogenic stimuli in vivo (5) (6) (7) (8) . Interestingly, both matrix modification and activation of growth factors may be facilitated by the urokinasetype plasminogen activator (uPA; ref. 9) . A role of uPA in the control of liver regeneration is readily inferred from the findings that hepatocyte proliferation is transiently impaired after partial hepatectomy of uPA-deficient mice (10) . Although the mechanism or mechanisms used by uPA to modulate liver regeneration are unknown, the uPA-mediated conversion of plasminogen to the active protease plasmin and the subsequent proteolytic degradation of ECM components may be biologically important in liver regeneration and remodeling (9) .
The plasminogen activator͞plasmin system is critical to the maintenance of hemostasis and vascular patency through degradation of fibrin and seems to be important to a variety of physiological processes, such as tissue remodeling and cell migration associated with tissue repair (11) . Plasminogendeficient mice develop to term, grow to adulthood, and are capable of reproduction (12) . Nevertheless, the phenotypic consequences of plasminogen deficiency are severe and include progressive microvascular thrombosis, delayed wound healing, and reduced life expectancy (11) (12) (13) (14) (15) . Notably, the genetic elimination of circulating fibrinogen in plasminogen-deficient mice was shown to result in a complete rescue from all of the known spontaneous phenotypic abnormalities caused by plasminogen deficiency, suggesting that fibrinolysis is the major physiological role of plasminogen (16) . However, a broader functional role for plasmin outside fibrinolysis in pathological contexts or specialized settings is likely, perhaps through the direct or indirect degradation of ECM (17) and͞or activation of latent growth factors (18, 19) . To define the role of plasminogen in hepatic proliferative response and ECM remodeling more precisely, we studied liver repair after a toxic injury in mice genetically engineered to lack plasminogen, fibrinogen, or both. We report that the loss of plasminogen has no obvious untoward effect on hepatocyte proliferation but leads to a severe impairment in the remodeling of the hepatic lobular architecture. The abnormal repair caused by plasminogen deficiency is not rescued by genetically superimposing the loss of the fibrinogen A␣ chain gene and points to a fibrinolysis-independent role of plasminogen in the liver. (12, 16, 20) . The genotypes of mice were established by multiplex PCR by using specific primers that identify endogenous and targeted alleles for the plasminogen and fibrinogen genes and tail or ear biopsy DNA as template (16 Liver Injury. Gene-targeted and control mice were injected intraperitoneally with 0.5 ml of CCl 4 per kg of body weight as a 50% (vol͞vol) solution in corn oil (21) . Mice were examined daily and killed on days 2-70 after CCl 4 . At the time of death, mice were weighed and anesthetized intramuscularly with 0.1 ml of ketamine:xylazine:acepromazine (4:1:1) per 30 g of body weight, and blood samples were collected from the inferior vena cava. Liver samples were harvested from the same region of the liver lobes to reduce sampling variability among experimental and control mice. The extent of injury was determined in stained liver sections by using computer-assisted morphometry (National Institutes of Health image͞ppc 1.56b30). For such analyses, the contour of areas of centrilobular injury was outlined completely, and the area within the drawing was used as a unit. For each liver, the cross-sectional areas within a minimum of 5 randomly selected units were analyzed without prior knowledge of the genotypes. Determination of serum albumin, alanine aminotransferase, and bilirubin was performed in plasma by using an automated enzymatic assay with the Vistros Chemistry Systems 950, and liver protein concentration was determined by the Bradford-method-based Bio-Rad assay (21) . The proliferative response after CCl 4 was measured by the incorporation of BrdUrd by hepatocytes in liver sections by using the Cell Proliferation Kit (Amersham Pharmacia; ref. 21) . For each liver sample, the hepatocyte-labeling index (percentage of hepatocytes incorporating BrdUrd) was calculated by counting BrdUrd-labeled and unlabeled hepatocytes in 10 high-power fields (Ϸ100 hepatocyte nuclei per field) by an investigator unaware of animal genotype.
Materials and Methods
Fibrinogen and Trichrome Stains. Fibrinogen immunostaining in liver sections was done with a rabbit anti-mouse antiserum as described (12) and with the Vectastain ABC-AP detection system (Vector Laboratories). Fast Red TR͞Naphthol AS-MX (Sigma) was used to detect alkaline phosphatase activity in situ.
The standard Mason's trichrome staining procedure was used to detect connective tissue proteins (such as collagen) in liver sections of control and experimental animals. mice experienced a gradual restoration of normal gross appearance over a 7-to 14-day observation period. In contrast, Plg o livers remained overtly diseased on day 14, having the same diffuse pale͞lacy gross appearance that had been seen on day 2 after CCl 4 .
Results

Abnormal Tissue Remodeling in Plg
To examine the development and resolution of the injury at the cellular level, microscopic analyses were performed in Plg o and Plg ϩ livers. On day 2 after injury, liquefaction necrosis was present in centrilobular hepatocytes in both genotypes, with minimal inflammation and intact cellular components in the unaffected areas of the liver lobule (Fig. 2) . Venular and sinusoidal endothelial cells, Kupffer cells, and bile duct cells appeared unaffected. Computer-based morphometric analyses of diseased areas showed that CCl 4 induced a similar extent of injury in livers of both genotypes, identifying no increased susceptibility of Plg o mice to the initial toxic insult (data not shown). Systematic analysis of samples of each one of the four liver lobes on days 7, 14, 30, and 70 showed that Plg ϩ livers experienced a nearly complete resolution of the centrilobular injury and normalization of the lobular architecture by day 7. A few localized areas of residual centrilobular inflammation were observed within the occasional focal lesions of Plg ϩ livers. In contrast, the microscopic appearance of Plg o livers on days 7-30 was characterized by prominent centrilobular lesions that were indistinguishable to the lesions noted on day 2 after CCl 4 (Fig. 2). By day 30, the same pattern of injury was still present, but normal-appearing hepatocytes were occasionally seen within a few injured areas, indicating that Plg o mice maintained at least some potential to repopulate the diseased areas (data not shown). The predominant finding at this time point, however, was the ongoing persistence of the centrilobular lesion seen in Plg o livers. On day 70 after CCl 4 , all of the centrilobular areas were still abnormal, but the eosinophilic appearance of the injured areas had been replaced by normal-appearing hepatocytes amidst basophilic amorphous granular deposits of dystrophic calcifications, a nonspecific histologic alteration encountered in areas of long-standing injury (Fig. 2) . In Plg ϩ livers, hepatic histology was essentially normal on day 70, except for rare foci of slight dystrophic calcification (present in Ϸ1-2% of centrilobular regions examined).
A single injection of CCl 4 would be expected to induce an acute hepatic injury but not the persistent injury observed in Plg o littermates. In animals of both genotypes, serum alanine aminotransferase levels (marker of liver cell injury) increased nearly 100-fold by day 2 after CCl 4 and subsequently returned to baseline levels by day 7 in a parallel fashion (data not shown), which is consistent with an acute CCl 4 injury that is short-lived, regardless of animal genotype. Despite the absence of ongoing liver injury, however, Plg o mice were unable to remove necrotic cells and repopulate the centrilobular injury with normal hepatocytes. (Fig. 3) . Therefore, it seemed that the normal proliferative response in Plg o livers noted 2 days after CCl 4 provided these livers with an appropriate cellular mass to maintain physiologic function, as supported by normal serum albumin and bilirubin levels in Plg Based on these findings, we reasoned that if Plg o livers could mount an adequate proliferative response but were unable to (Fig. 4) . On day 7, fibrin deposition was no longer detected in Plg ϩ livers, which coincided with normalization of histology. In contrast, accumulation of fibrin or fibrin-related material was easily detected in diseased centrilobular zones of Plg o livers on day 14 (Fig. 4) and for as long as 30 days after CCl 4 (data not shown). Fibrin was a component of the lobular spaces previously occupied by injured hepatocytes, and no fibrin deposits were seen in sinusoidal spaces, in the central veins, or in the nonaffected areas of the lobule. These findings are consistent with an impediment in the clearance of fibrin from diseased areas, as reported for other models of tissue injury (11, 15, 22) . The persistent fibrin deposition within the injured hepatic foci of Plg o mice suggested-but did not provethat this matrix component may form a mechanical impediment to the removal of necrotic debris and to the reconstitution of the centrilobular zones by normal hepatocytes in the absence of plasmin-mediated proteolysis.
Fibrin Deficiency Does Not Rescue the Abnormal Repair of Plg o Livers.
To determine the role of fibrin in these processes directly, we examined the liver repair in mice with a combined deficiency in plasminogen and fibrinogen. 
Discussion
These studies identify a major defect in hepatic tissue remodeling in plasminogen-deficient mice in a well established model of toxic liver injury. Neither the initial development of the hepatic injury by CCl 4 nor the proliferative response was influenced by the presence of plasminogen; however, the ability of the liver to clear necrotic tissue and to repopulate and organize the diseased areas by regenerating hepatocytes was dramatically impaired by the lack of plasminogen. As a consequence, Plg o livers had areas of persistent centrilobular injury. Only several weeks after hepatic repair was complete in control animals did the livers of Plg o mice show evidence of repair and cellular repopulation of damaged centrilobular zones. The development of marked dystrophic calcifications in the injured zones led to a grossly diseased appearance and persistently abnormal hepatic architecture as long as 2.5 months after toxic injury. Despite the persistence of the diseased areas, Plg o livers had no evidence of ongoing cellular injury and had normal synthetic function, In Plg ϩ livers, resolution of injury is accompanied by the timely removal of fibrin. In the absence of plasminogen, fibrin deposits persist up to day 14 after toxic injury; at day 70, minimal residual immunostaining is seen in the area of dystrophic calcification (arrows). (Magnification: ϫ200.) consistent with the appropriate proliferative response documented after the toxic insult. Notably, the acquisition of a nonreplicating quiescent phenotype by hepatocytes after the initial surge of DNA synthesis recapitulates the normal proliferative profile that follows CCl 4 and shows that plasminogen deficiency does not impair this biological process.
The coordinate entry of the liver cells into the cell cycle is key to an adequate restoration of the cellular mass after an injury. The normal proliferative response observed in Plg o livers suggests that plasmin-mediated proteolysis is not crucial to the mitotic response during liver regeneration through modification of ECM components and͞or activation of growth factors (9, 23) . These findings are of particular interest in view of the recent report of delayed hepatocellular proliferation and increased foci of cellular necrosis after Ϸ70% partial hepatectomy in mice lacking uPA (10) . The seemingly different effects of uPA and plasminogen deficiency on hepatocyte proliferation may be attributed to the use of two different models of liver injury. In partial hepatectomy, removal of two-thirds of the liver mass triggers a regenerative response in the absence of cell death, inflammation, or fibrosis, whereas CCl 4 injury induces cellular proliferation in addition to all of these three biological processes (24) . The basic cellular and molecular steps that take place during liver regeneration, however, are shared by both models except for differences related to the timing of the molecular response and involvement of progenitor cells (24, 25) . Moreover, the presence of injured hepatocytes in models of acute injury adds a reparative dimension to the regenerative response, in which necrotic cells must be removed to allow proliferative hepatocytes to repopulate the diseased area. In this regard, studies in Plg o livers highlight the reparative dimension that takes place after a toxic injury. Without plasmin-mediated proteolysis, removal of necrotic hepatocytes is profoundly impaired and produces a persistent diseased centrilobular appearance despite an adequate proliferative response.
Although not yet directly documented, uPA-and plasminogen-deficient mice may have differences in hepatic regeneration based on either (i) the availability of tissue-type plasminogen activator-mediated activation of plasminogen in uPA-deficient mice or (ii) uPA-mediated cleavage of a biologically relevant nonplasminogen substrate. For example, uPA may stimulate liver cell proliferation directly through the activation of hepatocyte growth factor (23, 26) , a property not yet established for plasminogen. However, the simultaneous enrollment of mice lacking plasminogen activators or plasminogen in liver regeneration experiments with partial hepatectomy or CCl 4 will be necessary to establish definitively any independent role of these proteases in the proliferative response of the liver. To this end, applying the same model of CCl 4 injury used for Plg o mice, we have observed a similar defective tissue repair in uPA-deficient mice, which parallels the findings in Plg o livers (J.A.B., unpublished work). Thus, we favor a model in which local plasmin generation is central to liver repair, and one potential mechanism by which plasmin contributes to the reparative process is in the clearance of necrotic cell debris and associated matrix components.
One matrix component associated with damaged tissues that might present a particularly strong impediment to tissue repair in the absence of plasminogen is fibrin. Consistent with this view, plasminogen-deficient mice have a profound impediment in wound repair in the skin that is associated with a decreased rate of keratinocyte migration from the wound edges (11) . This impediment in tissue repair in plasminogen-deficient mice seems to be due to the absence of plasmin-mediated fibrinolysis, because the simultaneous removal of circulating fibrinogen corrects the abnormal skin healing times seen in Plg o mice (16) . In contrast, genetically superimposing fibrinogen deficiency in Plg o mice does not fully correct the reparative process in CCl 4 -injured livers, pointing to a possible role of plasminogen outside fibrinolysis in the hepatic microenvironment. However, it should be noted that Fib o livers carry the targeted inactivation of the gene coding for the A␣ fibrinogen chain (20) . Although correct assembly of all three fibrinogen polypeptide chains has been shown to be essential for secretion both in vitro and in vivo, it is possible that the intracellular pool of B␤-and ␥-chains released from necrotic hepatocytes in Fib o mice presents a clearance challenge in the absence of plasmin. However, this hypothesis would require that very small quantities of intracellular fibrinogen B␤-and ␥-chains or their derivatives be sufficient to impede repair, because fibrinogen-related material was essentially undetectable in diseased areas of Fib o or Plg o ͞Fib o livers in sections immunostained with a polyclonal antibody that recognizes all three chains of fibrinogen. Although we cannot yet formally exclude the possibility that fibrinogen B␤ or ␥ chains released from necrotic hepatocytes constitutes an impediment to hepatic repair in plasminogen-deficient mice, the data suggest that plasmin may be important in hepatic tissue repair via a mechanism outside fibrin clearance. Interestingly, in addition to fibrinogen, other matrix glycoproteins such as fibronectin and tenascin are components of the provisional matrix after an acute CCl 4 -induced liver injury (27) . Plasminogen may be involved in the in vivo clearance of these and other matrix components either directly or through the activation of procollagenase and growth factors (28) . Although no data are presently available on growth factor and zymogen activation in Fib o or Plg o ͞Fib o livers, an impairment in either one of these processes by plasminogen deficiency could conceivably result in a reduction of the matrixdirected proteolysis and impair remodeling of the hepatic scaffold during liver regeneration.
Plasminogen-deficient mice may provide a valuable in vivo model for studies concerning the role of impaired proteolysis in the development of cirrhosis, an irreversible state of severe liver dysfunction that follows chronic, not self-limited injury. Central to cirrhosis is a disruption in the balance between production and removal of ECM proteins (29) . Consistent with the proposed role of plasmin in the degradation of ECM proteins, our data show that plasminogen deficiency leads to a significant accumulation of proteins after a single toxic insult. Thus, the use of Plg o mice in models of chronic liver injury offers an unique opportunity to explore the role of impaired proteolysis in the development of cirrhosis. Because excessive accumulation of matrix elements plays an integral role in this form of abnormal liver repair, Plg o mice may be particularly advantageous in addressing whether a therapeutically targeted plasmin-mediated proteolysis can be used to correct alterations in matrix homeostasis. 
